A systemmatic literature review on indirect costs of women with breast cancer

Abstract Introduction The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indirect costs of breast cancer. Methods English literature databases from...

Full description

Bibliographic Details
Main Authors: Saeed Mohammadpour, Samira Soleimanpour, Javad Javan-Noughabi, Nasrin Aboulhasanbeigi Gallehzan, Ali Aboutorabi, Reza Jahangiri, Rafat Bagherzadeh, Julia F. Gorman, Ali Nemati
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Online Access:https://doi.org/10.1186/s12962-022-00408-6
_version_ 1797980154812694528
author Saeed Mohammadpour
Samira Soleimanpour
Javad Javan-Noughabi
Nasrin Aboulhasanbeigi Gallehzan
Ali Aboutorabi
Reza Jahangiri
Rafat Bagherzadeh
Julia F. Gorman
Ali Nemati
author_facet Saeed Mohammadpour
Samira Soleimanpour
Javad Javan-Noughabi
Nasrin Aboulhasanbeigi Gallehzan
Ali Aboutorabi
Reza Jahangiri
Rafat Bagherzadeh
Julia F. Gorman
Ali Nemati
author_sort Saeed Mohammadpour
collection DOAJ
description Abstract Introduction The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indirect costs of breast cancer. Methods English literature databases from 2000 to 2020 were searched to find studies related to the objective of the present review. Study selection and data extraction was undertaken independently by two authors. Also, quality assessment was done using a checklist designed by Stunhldreher et al. Results The current study chose 33 studies that were eligible from a total of 2825 records obtained. The cost of lost productivity due to premature death based on human capital approach ranged from $22,386 to $52 billion. The cost burden from productivity lost due to premature death based on friction cost approach ranged from $1488.61 to $4,518,628.5. The cost burden from productivity lost due to morbidity with the human capital approach was reported as $126,857,360.69 to $596,659,071.28. The cost of lost productivity arising from informal caregivers with the human capital approach was $297,548.46 to $308 billion. Conclusion Evaluation of the existing evidence revealed the indirect costs of breast cancer in women to be significantly high. This study did a thorough review on the indirect costs associated with breast cancer in women which could serve as a guide to help pick the appropriate method for calculating the indirect costs of breast cancer based on existing methods, approach and data. There is a need for calculations to be standardised since the heterogeneity of results in different domains from various studies makes it impossible for comparisons to be made among different countries.
first_indexed 2024-04-11T05:51:09Z
format Article
id doaj.art-712151bfcadb49dea58e3f18fe417ab8
institution Directory Open Access Journal
issn 1478-7547
language English
last_indexed 2024-04-11T05:51:09Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Cost Effectiveness and Resource Allocation
spelling doaj.art-712151bfcadb49dea58e3f18fe417ab82022-12-22T04:42:05ZengBMCCost Effectiveness and Resource Allocation1478-75472022-12-0120111910.1186/s12962-022-00408-6A systemmatic literature review on indirect costs of women with breast cancerSaeed Mohammadpour0Samira Soleimanpour1Javad Javan-Noughabi2Nasrin Aboulhasanbeigi Gallehzan3Ali Aboutorabi4Reza Jahangiri5Rafat Bagherzadeh6Julia F. Gorman7Ali Nemati8Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical SciencesDepartment of Medical Library and Information Science, School of Health Management and Information Sciences, Iran University of Medical SciencesSocial Determinants of Health Research Center, Mashhad University of Medical SciencesDepartment of Health Economics, School of Health Management and Information Sciences, Iran University of Medical SciencesDepartment of Health Economics, School of Health Management and Information Sciences, Iran University of Medical SciencesDepartment of Health Economics, Health Management and Economics Research Center, Iran University of Medical SciencesEnglish Language Department, School of Health Management and Information Sciences, Iran University of Medical SciencesGraduate School of Humanities and Social Sciences, University of MelbourneDepartment of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical SciencesAbstract Introduction The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indirect costs of breast cancer. Methods English literature databases from 2000 to 2020 were searched to find studies related to the objective of the present review. Study selection and data extraction was undertaken independently by two authors. Also, quality assessment was done using a checklist designed by Stunhldreher et al. Results The current study chose 33 studies that were eligible from a total of 2825 records obtained. The cost of lost productivity due to premature death based on human capital approach ranged from $22,386 to $52 billion. The cost burden from productivity lost due to premature death based on friction cost approach ranged from $1488.61 to $4,518,628.5. The cost burden from productivity lost due to morbidity with the human capital approach was reported as $126,857,360.69 to $596,659,071.28. The cost of lost productivity arising from informal caregivers with the human capital approach was $297,548.46 to $308 billion. Conclusion Evaluation of the existing evidence revealed the indirect costs of breast cancer in women to be significantly high. This study did a thorough review on the indirect costs associated with breast cancer in women which could serve as a guide to help pick the appropriate method for calculating the indirect costs of breast cancer based on existing methods, approach and data. There is a need for calculations to be standardised since the heterogeneity of results in different domains from various studies makes it impossible for comparisons to be made among different countries.https://doi.org/10.1186/s12962-022-00408-6Breast neoplasmsBreast cancerIndirect costFemaleSystematic review
spellingShingle Saeed Mohammadpour
Samira Soleimanpour
Javad Javan-Noughabi
Nasrin Aboulhasanbeigi Gallehzan
Ali Aboutorabi
Reza Jahangiri
Rafat Bagherzadeh
Julia F. Gorman
Ali Nemati
A systemmatic literature review on indirect costs of women with breast cancer
Cost Effectiveness and Resource Allocation
Breast neoplasms
Breast cancer
Indirect cost
Female
Systematic review
title A systemmatic literature review on indirect costs of women with breast cancer
title_full A systemmatic literature review on indirect costs of women with breast cancer
title_fullStr A systemmatic literature review on indirect costs of women with breast cancer
title_full_unstemmed A systemmatic literature review on indirect costs of women with breast cancer
title_short A systemmatic literature review on indirect costs of women with breast cancer
title_sort systemmatic literature review on indirect costs of women with breast cancer
topic Breast neoplasms
Breast cancer
Indirect cost
Female
Systematic review
url https://doi.org/10.1186/s12962-022-00408-6
work_keys_str_mv AT saeedmohammadpour asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT samirasoleimanpour asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT javadjavannoughabi asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT nasrinaboulhasanbeigigallehzan asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT aliaboutorabi asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT rezajahangiri asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT rafatbagherzadeh asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT juliafgorman asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT alinemati asystemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT saeedmohammadpour systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT samirasoleimanpour systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT javadjavannoughabi systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT nasrinaboulhasanbeigigallehzan systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT aliaboutorabi systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT rezajahangiri systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT rafatbagherzadeh systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT juliafgorman systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer
AT alinemati systemmaticliteraturereviewonindirectcostsofwomenwithbreastcancer